Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Idro

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Malaria Journal|July 30, 2017
Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malariaDag Holmberg, Elisabeth Franzén-Röhl, Richard Idro, et al.
BMC Medicine|July 28, 2021
Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malariaAndrea L Conroy, Robert O Opoka, Paul Bangirana, et al.
JAMA|May 24, 2007
Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan childrenRichard Idro, Moses Ndiritu, Bernhards Ogutu, et al.
Trials|April 4, 2023
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trialThandile Nkosi-Gondwe, Bjarne Robberstad, Robert Opoka, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Neurocognitive Impairment in Ugandan Children with Sickle Cell Anemia Compared to Sibling Controls: A cross-sectional studyPaul Bangirana, Amelia K Boehme, Annet Birabwa, et al.
Plos One|September 29, 2020
Economic burden of the persistent morbidity of nodding syndrome on caregivers in affected households in Northern UgandaLugala Samson Yoane Latio, Nguyen Hai Nam, Jaffer Shah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2019
Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral MalariaDibyadyuti Datta, Andrea L Conroy, Peter F Castelluccio, et al.
Epilepsia Open|May 25, 2021
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long-standing nodding syndrome: A case-control studyRodney Ogwang, Dennis Muhanguzi, Kioko Mwikali, et al.
BMC Neurology|March 8, 2019
Doxycycline for the treatment of nodding syndrome (DONS); the study protocol of a phase II randomised controlled trialRichard Idro, Ronald Anguzu, Rodney Ogwang, et al.
Pediatric Blood & Cancer|April 22, 2025
Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing RisksBill Wambaka, Amiirah Mpungu, Vincent Mboizi, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Malaria Journal|July 30, 2017
Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malariaDag Holmberg, Elisabeth Franzén-Röhl, Richard Idro, et al.
BMC Medicine|July 28, 2021
Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malariaAndrea L Conroy, Robert O Opoka, Paul Bangirana, et al.
JAMA|May 24, 2007
Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan childrenRichard Idro, Moses Ndiritu, Bernhards Ogutu, et al.
Trials|April 4, 2023
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trialThandile Nkosi-Gondwe, Bjarne Robberstad, Robert Opoka, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Neurocognitive Impairment in Ugandan Children with Sickle Cell Anemia Compared to Sibling Controls: A cross-sectional studyPaul Bangirana, Amelia K Boehme, Annet Birabwa, et al.
Plos One|September 29, 2020
Economic burden of the persistent morbidity of nodding syndrome on caregivers in affected households in Northern UgandaLugala Samson Yoane Latio, Nguyen Hai Nam, Jaffer Shah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2019
Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral MalariaDibyadyuti Datta, Andrea L Conroy, Peter F Castelluccio, et al.
Epilepsia Open|May 25, 2021
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long-standing nodding syndrome: A case-control studyRodney Ogwang, Dennis Muhanguzi, Kioko Mwikali, et al.
BMC Neurology|March 8, 2019
Doxycycline for the treatment of nodding syndrome (DONS); the study protocol of a phase II randomised controlled trialRichard Idro, Ronald Anguzu, Rodney Ogwang, et al.
Pediatric Blood & Cancer|April 22, 2025
Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing RisksBill Wambaka, Amiirah Mpungu, Vincent Mboizi, et al.
Pageof 16